Samjin Pharmaceuticals Co., Ltd. (005500.KS) KSC

20,700.00

-50(-0.24%)

Updated at December 05 12:44PM

Currency In KRW

Valuation

Market Cap227.9B
Enterprise Value345.9B
P/E Ratio12.78
PEG Ratio-0.26
Price/Sales Ratio0.81
Price/Book Ratio0.98
Enterprise/Revenue1.22
Enterprise/EBITDA6.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.1

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue308.35B
Revenue/Share25,349.62
Gross Profit128.97B
EBITDA65.92B
Net Income39.23B
Diluted EPS3,110.66

Balance Sheet

Total Cash5.14B
Total Cash/Share419.47
Total Debt131.31B
Total Debt/Equity0.51
Current Ratio1.21
Book Value Per Share21,085.07

Price History

52-Week Change12.57
52-Week High21,300
52-Week Low16,590
Moving Average 50 Days19,778.6
Moving Average 200 Days18,929.55

Statistics

Average Volume48,111
Shares Outstanding12.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate800
Trailing Annual Dividend Yield3.88
Payout Ratio0
Last Split Factor1031:1000
Last Split DateDecember 29, 2010